Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Mayo Clinic Health System-wide Neurological, Vascular and Neurovascular Events With SARS-CoV-2- Part II

NCT05220514 is registered in ClinicalTrials.gov with Mayo Clinic as lead sponsor.

NCT NCT05220514
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05220514 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Mayo Clinic Health System-wide Neurological, Vascular and Neurovascular Events With SARS-CoV-2- Part II
Lead sponsor
Mayo Clinic
Phase
Observational
Overall status
Completed
Start date
January 19, 2022
Completion date
November 30, 2024
Enrollment
71 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

covid-19, sar-cov-2